Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 17/20 | 0.65 |
| ▸ | CA1 | P00915 | 16/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.63 |
| ▸ | RECQL | P46063 | 1/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.63 |
| ▸ | CA9 | Q16790 | 7/20 | 0.61 |
| ▸ | CA12 | O43570 | 4/20 | 0.61 |
| ▸ | CA6 | P23280 | 1/20 | 0.55 |
| ▸ | CA5A | P35218 | 1/20 | 0.55 |
| ▸ | CA7 | P43166 | 1/20 | 0.55 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12049673 | 0.87 | ALDH1A1 (0.59) | CA2CA1ALDH1A1RECQLSMN1; SMN2 | |
| SCHEMBL5968076 | 0.83 | ALDH1A1 (0.63) | CA2CA1ALDH1A1RECQLSMN1; SMN2 | |
| SCHEMBL31309573 | 0.82 | CA1 (0.70) | CA2CA1ALDH1A1CA9CA12 | |
| SCHEMBL4463532 | 0.82 | CA1 (0.70) | CA2CA1ALDH1A1CA9CA12 | |
| SCHEMBL6118940 | 0.82 | CA1 (0.69) | CA2CA1CA9CA12CA6 | |
| SCHEMBL3815711 | 0.81 | CA1 (0.66) | CA2CA1SMN1; SMN2CA9CA12 | |
| SCHEMBL14577802 | 0.81 | CA1 (0.67) | CA2CA1CA9CA12CA6 | |
| SCHEMBL29988500 | 0.81 | CA1 (0.66) | CA2CA1SMN1; SMN2CA9CA12 | |
| SCHEMBL27576154 | 0.81 | CA2 (0.66) | CA2CA1CA9CA12CA6 | |
| SCHEMBL12503489 | 0.80 | CA2 (0.61) | CA2CA1CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12570994-B2 | Plants having increased tolerance to herbicides | BASF Agro B.V. (NL) | 2026-03-10 | — | — | US | disclosed |
| US-11572571-B2 | Plants having increased tolerance to herbicides | BASF Agro B.V. (NL) | 2023-02-07 | — | — | US | disclosed |
| US-20220315943-A1 | PLANTS HAVING INCREASED TOLERANCE TO HERBICIDES | BASF AGRO BV (NL) | 2022-10-06 | — | — | US | disclosed |
| US-11311014-B2 | Crystalline forms of ethyl[3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetate | BASF SE (DE) | 2022-04-26 | — | — | US | disclosed |
| US-11274313-B2 | Plants having increased tolerance to herbicides | BASF Agro B.V. (NL) | 2022-03-15 | — | — | US | disclosed |
| CN-113943234-A | Preparation method of sulfonylphenylurea herbicide safener | 常州大学 | 2022-01-18 | — | — | CN | disclosed |
| US-11058117-B2 | Benzoxaborole compounds | BASF SE (DE) | 2021-07-13 | — | — | US | disclosed |
| US-20200267987-A1 | BENZOXABOROLE COMPOUNDS | BASF SE (DE) | 2020-08-27 | — | — | US | disclosed |
| EP-3684182-A1 | HERBICIDALLY ACTIVE PYRIDYL-/PYRIMIDYL-PYRIMIDINE DERIVATIVES | Syngenta Participations AG (CH) | 2020-07-29 | — | — | EP | disclosed |
| WO-2019057720-A1 | HERBICIDALLY ACTIVE PYRIDYL-/PYRIMIDYL-PYRIMIDINE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2019-03-28 | — | — | WO | disclosed |
| EP-1889846-A1 | Purine derivatives as A2a agonists | Novartis AG (CH) | 2008-02-20 | — | — | EP | disclosed |
| EP-1221848-A1 | SELECTIVE HERBICIDES ON THE BASIS OF N-ARYL-TRIAZOLINE(THI)ONES | Bayer Aktiengesellschaft (DE) | 2002-07-17 | — | — | EP | disclosed |
| WO-2001022819-A1 | SELECTIVE HERBICIDES ON THE BASIS OF N-ARYL-TRIAZOLINE(THI)ONES | BAYER AKTIENGESELLSCHAFT (DE) | 2001-04-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570994-B2 | Plants having increased tolerance to herbicides | PPOX, MTR, DAO | CA2 2391/4885CA1 3709/4885ALDH1A1 992/4885 |
| US-11572571-B2 | Plants having increased tolerance to herbicides | PPOX, PNPO, PAOX | CA2 1365/4885CA1 2717/4885ALDH1A1 1116/4885 |
| US-20200267987-A1 | BENZOXABOROLE COMPOUNDS | BROX, BBOX1, BZW2 | CA2 1012/4885CA1 1515/4885ALDH1A1 397/4885 |
| US-11058117-B2 | Benzoxaborole compounds | BROX, BBOX1, BZW2 | CA2 1012/4885CA1 1515/4885ALDH1A1 397/4885 |
| US-11311014-B2 | Crystalline forms of ethyl[3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl)phenoxy]-2-pyridyloxy]acetate | RCC1, CYP4X1, HAX1 | CA2 18/4885CA1 258/4885ALDH1A1 388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.